Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...

IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped ...

Shares of IQVIA Holdings Inc. IQV slipped 2.97% to $185.86 Thursday, on what proved to be an all-around rough trading session ...

Medpace and Iqvia stocks surged Tuesday after the duo kicked off earnings season with unexpectedly strong reports.

Clinical research company IQVIA (NYSE: IQV) reported Q2 CY2025 results , with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint ...

Contract research firm IQVIA Holdings posted second-quarter profit and revenue above Wall Street expectations on Tuesday, as demand rose for its healthcare data and analytics services, sending shares ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and ...

RESEARCH TRIANGLE PARK, N.C., May 06, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

IQVIA Holdings' results in Q1 2025 were good, surpassing analysts' estimations. Click here to find out why I rate IQV stock as a hold.

He joined IQVIA in 2003 and has been rising up the ranks ever since, from director of stats to leading a team over more than 50 to incorporate artificial intelligence into the company’s suite of ...

This was the stock's sixth consecutive day of losses.